Skip to content
DataLookout
Menu

NCT04063501

Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 9 versions: 8 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Dec 2026 to Dec 2027
    • Eligibility criteria expanded, about 8 words
    • Study completion pushed from Feb 2027 to Feb 2028
  2. Minor Enrollment target: 40 to 48v8
  3. Notable Primary completion date: Dec 2024 to Dec 2026
    • Enrollment target: 30 to 40
    • Study completion date: Feb 2026 to Feb 2027
    v7
  4. Notable Enrollment target: 80 to 30v6
  5. Minor Primary completion date: Sep 2024 to Dec 2024
    • Study completion date: Sep 2024 to Feb 2026
    • Start date: Mar 2, 2021 to Feb 9, 2021
    • Site contact updated
    v5
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Start date: Sep 1, 2020 to Mar 2, 2021v4
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Sep 2020 to Sep 2024
    • Start date changed from estimate of Sep 2019 to Sep 1, 2020
    • Site details revised
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Progression-free survival (PFS)
Timeframe: 3 Years
Microbiota signatures in lower and upper airways
Timeframe: 3 Years
Microbiota signatures in stool
Timeframe: 3 Years

Arms and interventions

Advanced stage unresectable Non-Small Cell Lung Cancer

Adult patients with a diagnosis of advanced stage unresectable Non-Small Cell Lung Cancer and indication for PD-1 blockade treatment (either as monotherapy or combined with chemotherapy)

Other: Bronchoscopy, Research Procedures

Sites

1 site in 1 country

  • NYU Langone HealthNew York, New York, United States